215 related articles for article (PubMed ID: 24238051)
1. Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma.
Beninato T; Scognamiglio T; Kleiman DA; Uccelli A; Vaca D; Fahey TJ; Zarnegar R
Surgery; 2013 Dec; 154(6):1331-6; discussion 1336. PubMed ID: 24238051
[TBL] [Abstract][Full Text] [Related]
2. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
[TBL] [Abstract][Full Text] [Related]
3. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
Ghossein R; Katabi N; Dogan S; Shaha AR; Tuttle RM; Fagin JA; Ganly I; Xu B
Histopathology; 2024 Jun; 84(7):1130-1138. PubMed ID: 38528726
[TBL] [Abstract][Full Text] [Related]
4. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
[TBL] [Abstract][Full Text] [Related]
5. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
[TBL] [Abstract][Full Text] [Related]
6. Association of patient age with high-risk pathologic features in papillary thyroid cancer.
Niemann AC; Reid AT; Smith J; Hammond J; DeBolle SA; Wei I; Soong-Ho Lee C; Hughes DT
J Surg Res; 2017 May; 211():228-232. PubMed ID: 28501122
[TBL] [Abstract][Full Text] [Related]
7. Surgical Management of Familial Papillary Thyroid Microcarcinoma: A Single Institution Study of 94 Cases.
Sung TY; Lee YM; Yoon JH; Chung KW; Hong SJ
World J Surg; 2015 Aug; 39(8):1930-5. PubMed ID: 25894401
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma.
Jung TS; Kim TY; Kim KW; Oh YL; Park DJ; Cho BY; Shong YK; Kim WB; Park YJ; Jung JH; Chung JH
Endocr J; 2007 Apr; 54(2):265-74. PubMed ID: 17379963
[TBL] [Abstract][Full Text] [Related]
9. Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Associated With Aggressive Histopathological Features and a Poor Outcome: Results of a Large Multicentric Study.
Chereau N; Giudicelli X; Pattou F; Lifante JC; Triponez F; Mirallié E; Goudet P; Brunaud L; Trésallet C; Tissier F; Leenhardt L; du Montcel ST; Menegaux F
J Clin Endocrinol Metab; 2016 Dec; 101(12):4603-4610. PubMed ID: 27626975
[TBL] [Abstract][Full Text] [Related]
10. Cytological diagnosis of papillary thyroid carcinoma with tall cells on ThinPrep liquid-based cytology.
Baum JE; Soong L; Scognamiglio T; Margolskee EM; Hoda RS; Rao R
Diagn Cytopathol; 2019 Jun; 47(6):541-546. PubMed ID: 30648353
[TBL] [Abstract][Full Text] [Related]
11. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
Arora N; Turbendian HK; Kato MA; Moo TA; Zarnegar R; Fahey TJ
Thyroid; 2009 May; 19(5):473-7. PubMed ID: 19348582
[TBL] [Abstract][Full Text] [Related]
12. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma.
Lee SH; Jung CK; Bae JS; Jung SL; Choi YJ; Kang CS
Diagn Cytopathol; 2014 Jan; 42(1):11-7. PubMed ID: 23754825
[TBL] [Abstract][Full Text] [Related]
14. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
16. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
17. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
[TBL] [Abstract][Full Text] [Related]
18. Aggressive Subtypes of Papillary Thyroid Carcinoma Smaller Than 1 cm.
Lee JS; Lee JS; Yun HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS
J Clin Endocrinol Metab; 2023 May; 108(6):1370-1375. PubMed ID: 36546348
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: A case control study.
Karatzas T; Charitoudis G; Vasileiadis D; Kapetanakis S; Vasileiadis I
Int J Surg; 2015 Jun; 18():64-8. PubMed ID: 25900600
[TBL] [Abstract][Full Text] [Related]
20. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]